Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 10 February

Jessica Amir
February 10, 2020

Morning Bell 7 February

Jessica Amir
February 7, 2020

Reporting season: Mirvac results

Jessica Amir
February 6, 2020

Morning Bell 6 February

Jessica Amir
February 6, 2020

Morning Bell 5 February

Jessica Amir
February 5, 2020

Morning Bell 4 February

Jessica Amir
February 4, 2020

Morning Bell 3 February

Jessica Amir
February 3, 2020

January Market Overview

Jessica Amir
January 31, 2020

Morning Bell 31 January

Jessica Amir
January 31, 2020

Morning Bell 29 January

Jessica Amir
January 29, 2020